Haichen Pharmaceutical: China Securities Regulatory Commission's approval for the company's initial public offering of shares

SZSI · Dec 28, 2016 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.